Clinical Trial Update: A Comparison Study of PF708 and Forteo in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study comparing PF708 to Forteo in healthy subjects to evaluate pharmacokinetics and safety for a teriparatide-related osteoporosis therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Forteo (teriparatide)
• PF708 (teriparatide biosimilar)

Snippet

Sponsor: Pfenex, Inc | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED